David Potter, MD, PhD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Gilead
    Date added: 
    08/03/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    ImmunoMet Therapeutics
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Nektar Therapeutics
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Takeda
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Seattle Genetics
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Innocrin Pharmaceuticals
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AstraZeneca
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    AbbVie
    Date added: 
    08/23/2023
  • Attribution: 
    Other
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Gilead
    Date added: 
    08/23/2023

Pages

Return to Best of ASCO 2024, Minneapolis